Latest Expert Opinions

Signal
Opinion
Expert
TOP PICK
TOP PICK
May 3, 2019
Has given up what Merck has gained. Likes the acquisition, and thinks the reaction is a bit overdone. Up almost 4% today, but still likes it. Yield is 3.37%. (Analysts’ price target is $58.00)
Show full opinionHide full opinion
Has given up what Merck has gained. Likes the acquisition, and thinks the reaction is a bit overdone. Up almost 4% today, but still likes it. Yield is 3.37%. (Analysts’ price target is $58.00)
TOP PICK
TOP PICK
May 3, 2019
Large cap diversified biotech company. Seeing shorts because of a patent dispute. Diversified pipeline of drugs. Valuation is attractive. Buy this as a basket. Yield is 3.27%. (Analysts’ price target is $206.95)
Show full opinionHide full opinion
Large cap diversified biotech company. Seeing shorts because of a patent dispute. Diversified pipeline of drugs. Valuation is attractive. Buy this as a basket. Yield is 3.27%. (Analysts’ price target is $206.95)